Qi‐dan‐dihuang decoction ameliorates renal fibrosis in diabetic rats via p38MAPK/AKT/mTOR signaling pathway
Authors:
- 8 March 2024
- journal article
- research article
- Published by Wiley in Environmental Toxicology
- Vol. 39 (6) , 3481-3499
Abstract
Context: Qi‐dan‐dihuang decoction (QDD) has been used to treat diabetic kidney disease (DKD), but the underlying mechanisms are poorly understood.Objective: This study reveals the mechanism by which QDD ameliorates DKD.Materials and Methods: The compounds in QDD were identified by high‐performance liquid chromatography and quadrupole‐time‐of‐flight tandem mass spectrometry (HPLC‐Q‐TOF‐MS). Key targets and signaling pathways were screened through bioinformatics. Nondiabetic Lepr db/m mice were used as control group, while Lepr db/db mice were divided into model group, dapagliflozin group, 1% QDD‐low (QDD‐L), and 2% QDD‐high (QDD‐H) group. After 12 weeks of administration, 24 h urinary protein, serum creatinine, and blood urea nitrogen levels were detected. Kidney tissues damage and fibrosis were evaluated by pathological staining. In addition, 30 mmol/L glucose‐treated HK‐2 and NRK‐52E cells to induce DKD model. Cell activity and migration capacity as well as protein expression levels were evaluated.Results: A total of 46 key target genes were identified. Functional enrichment analyses showed that key target genes were significantly enriched in the phosphatidylinositol 3‐kinase (PI3K)/protein kinase B (AKT) and mitogen‐activated protein kinase (MAPK) signaling pathways. In addition, in vivo and in vitro experiments confirmed that QDD ameliorated renal fibrosis in diabetic mice by resolving inflammation and inhibiting the epithelial‐mesenchymal transition (EMT) via the p38MAPK and AKT‐mammalian target of rapamycin (mTOR) pathways.Discussion and Conclusion: QDD inhibits EMT and the inflammatory response through the p38MAPK and AKT/mTOR signaling pathways, thereby playing a protective role in renal fibrosis in DKD.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2018A0303130320, 2018030310451)
- National Natural Science Foundation of China (81774212)
This publication has 51 references indexed in Scilit:
- Evaluation of the key active ingredients of ‘Radix Astragali and Rehmanniae Radix Mixture’ and related signaling pathways involved in ameliorating diabetic foot ulcers from the perspective of TCM-related theoriesJournal of Biomedical Informatics, 2021
- Clinical characteristics and management of patients with diabetes mellitus and stable coronary artery disease in daily clinical practice. The SCAD–DM RegistryHellenic Journal of Cardiology, 2021
- Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and ProspectiveChinese Journal of Integrative Medicine, 2019
- p38 MAPK Inhibitor (SB203580) and Metformin Reduces Aortic Protein Carbonyl and Inflammation in Non-obese Type 2 Diabetic RatsIndian Journal of Clinical Biochemistry, 2019
- Kaempferol attenuates diabetic nephropathy by inhibiting RhoA/Rho-kinase mediated inflammatory signallingBiomedicine & Pharmacotherapy, 2019
- Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stressEndocrine, 2018
- Clinical Research on Traditional Chinese Medicine compounds and their preparations for Amyotrophic Lateral SclerosisBiomedicine & Pharmacotherapy, 2017
- The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence AnalysesCurrent Protocols in Bioinformatics, 2016
- Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic ratsInternational Immunopharmacology, 2015
- Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney diseasePhytotherapy Research, 2010